tiprankstipranks
Trending News
More News >
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market

Cytosorbents (CTSO) Income Statement

Compare
479 Followers

Cytosorbents Income Statement

Last quarter (Q4 2024), Cytosorbents's total revenue was $6.52M, a decrease of -11.23% from the same quarter last year. In Q4, Cytosorbents's net income was $-7.88M. See Cytosorbents’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.59M$ 36.35M$ 29.36M$ 40.11M$ 39.45M
Gross Profit
$ 25.13M$ 21.95M$ 15.40M$ 29.06M$ 28.40M
Operating Expenses
$ 41.91M$ 53.60M$ 46.93M$ 51.81M$ 38.77M
Depreciation and Amortization
$ 1.74M$ 1.46M$ 1.13M$ 1.13M$ 660.79K
EBITDA
$ -19.26M$ -29.18M$ -30.00M$ -22.01M$ -9.71M
Operating Income
$ -16.79M$ -31.21M$ -31.52M$ -22.75M$ -10.37M
Other Income/Expenses
$ -5.62M$ 1.89M$ -2.38M$ -2.55M$ 1.41M
Pretax Income
$ -22.41M$ -29.32M$ -33.91M$ -25.30M$ -8.96M
Net Income
$ -20.72M$ -28.51M$ -32.81M$ -24.56M$ -7.84M
Per Share Metrics
Basic EPS
$ -0.38$ -0.65$ -0.75$ -0.57$ -0.20
Diluted EPS
$ -0.38$ -0.65$ -0.75$ -0.57$ -0.20
Weighted Average Shares Outstanding
54.43M 44.66M 43.57M 43.36M 38.82M
Weighted Average Shares Outstanding (Diluted)
54.43M 44.66M 43.57M 43.36M 38.82M
Currency in USD

Cytosorbents Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis